Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers
- PMID: 18985334
- DOI: 10.1007/s00240-008-0161-5
Role of overweight and obesity on the urinary excretion of promoters and inhibitors of stone formation in stone formers
Abstract
In recent decades there has been an increasing prevalence of urolitithiasis in many western countries and at the same time there has been an increasing progression of obesity that has reached epidemic proportions. The aim of the present study was to assess the influence of overweight/obesity on the metabolic risk factors for renal stone formation. We studied 799 renal stone formers (462 men and 337 women) who came to the clinic for metabolic risk factors evaluation. They were all studied with a standard protocol (two 24-h urine collections and serum parameters). They were divided according to their BMI in normal (BMI < 25) overweight (BMI 25-29.9) and obese (BMI > 30). Low-weight individuals were excluded. Overall, 487 of 799 (60.9%) patients had a BMI > 25, including 40.6% overweight and 20.3% obese. Among women 55.2% had normal weight, 25.5 were overweight, and 19.3% were Obese; among men 27.3% had normal weight, 51.7 were overweight, and 21% were obese. Age increased significantly with increasing BMI both in men and women. In women there was a significant increase in the excretion of oxalate, uric acid, phosphorus, creatinine, and sodium with increasing BMI, but no change was observed in calcium, magnesium, citrate, and urine pH. In men there was a significant increase in the excretion of oxalate, uric acid, creatinine, phosphorus, sodium, magnesium, and citrate with increasing BMI, no change in urinary calcium and significant progressive decrease in urinary pH. In this population of stone formers there was a high prevalence of overweight/obesity (60.9%). Both in men and women we found a significant increase in the urinary excretion of two promoters of stone formation, oxalate, and uric acid but no change in urinary calcium. There was either no change or increase in magnesium and citrate, inhibitors of crystallization, and a significant decrease in urine pH only in men.
Similar articles
-
The role of overweight and obesity in calcium oxalate stone formation.Obes Res. 2004 Jan;12(1):106-13. doi: 10.1038/oby.2004.14. Obes Res. 2004. PMID: 14742848
-
Obesity and urolithiasis: evidence of regional influences.Urolithiasis. 2017 Jun;45(3):271-278. doi: 10.1007/s00240-016-0908-3. Epub 2016 Aug 3. Urolithiasis. 2017. PMID: 27488444
-
Body size and 24-hour urine composition.Am J Kidney Dis. 2006 Dec;48(6):905-15. doi: 10.1053/j.ajkd.2006.09.004. Am J Kidney Dis. 2006. PMID: 17162145
-
The impact of body mass index on quantitative 24-h urine chemistries in stone forming patients: a systematic review and meta-analysis.Urolithiasis. 2018 Nov;46(6):523-533. doi: 10.1007/s00240-018-1044-z. Epub 2018 Feb 8. Urolithiasis. 2018. PMID: 29423725
-
Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.Arch Ital Urol Androl. 2015 Jul 7;87(2):105-20. doi: 10.4081/aiua.2015.2.105. Arch Ital Urol Androl. 2015. PMID: 26150027 Review.
Cited by
-
Preliminary analysis of serum electrolytes and body mass index in patients with and without urolithiasis.J Int Med Res. 2020 Jun;48(6):300060520925654. doi: 10.1177/0300060520925654. J Int Med Res. 2020. PMID: 32495668 Free PMC article.
-
Flexible Ureterorenoscopy Versus Extracorporeal Shock Wave Lithotripsy for the Treatment of Renal Pelvis Stones of 10-20 mm in Obese Patients.J Lasers Med Sci. 2015 Fall;6(4):162-6. doi: 10.15171/jlms.2015.12. Epub 2015 Oct 27. J Lasers Med Sci. 2015. PMID: 26705461 Free PMC article.
-
Hypocitraturia and hyperoxaluria after Roux-en-Y gastric bypass surgery.J Urol. 2010 Mar;183(3):1026-30. doi: 10.1016/j.juro.2009.11.022. Epub 2010 Jan 21. J Urol. 2010. PMID: 20096421 Free PMC article.
-
Conditions Favoring Increased COVID-19 Morbidity and Mortality: Their Common Denominator and its Early Treatment.Mo Med. 2021 Mar-Apr;118(2):113-115. Mo Med. 2021. PMID: 33840847 Free PMC article. Review.
-
Low-dose computed tomography of urolithiasis in obese patients: a feasibility study to evaluate image reconstruction algorithms.Diabetes Metab Syndr Obes. 2019 Apr 5;12:439-445. doi: 10.2147/DMSO.S198641. eCollection 2019. Diabetes Metab Syndr Obes. 2019. PMID: 31114274 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical